NovaShunt Announces the Launch of its New Corporate Identity: Sequana Medical

By Novashunt Ag, PRNE
Sunday, May 29, 2011

ZUG, Switzerland, May 30, 2011 -

NovaShunt AG has launched a new corporate identity and product branding
to support its goal of leadership in the area of fluid management within the
body. The company will now operate as Sequana Medical AG ( as it prepares for the upcoming launch of the
ALFApump(TM) System in Europe.

"There were a number of compelling reasons to rebrand NovaShunt,"
commented Noel Johnson, CEO. "We felt the name 'NovaShunt' was not well
aligned with our current technology or vision for the future. Also, we want
to make sure our company name is clearly differentiated from the names of our
products. Now is an ideal time to transition to a new company name, having
just completed a $25 million USD Series B financing round and as we prepare
for our first product launch."

NovaShunt's first product is the Automated Low-Flow Ascites (ALFA) Pump
System, a subcutaneously implanted battery-powered pump system that removes
excess abdominal fluid, known as ascites, by transferring it to the bladder
where it is eliminated through normal urination. Ascites is a common
complication in patients suffering from liver cirrhosis, certain cancers and
congestive heart failure.

"The ALFApump System has tremendous potential as a new therapeutic tool
for the management of fluid overload. Patients with persistent or refractory
ascites are faced today with poor treatment options that negatively impact
quality of life. Also, the healthcare system bears a very heavy burden of
care for these patients. We believe the ALFApump System can offer patients
the relief of fewer repeat interventions and better quality of life while
saving money and resources," stated Dan Rose, Vice President of Commercial

The rebranding was undertaken with the advice of milani design &
consulting (, a leading Swiss design firm. Sequana is an
ancient name which refers to the springs at the source of the river Seine
which were believed to have healing properties.

"As we prepare for the launch of our first product, we look forward to
introducing ourselves to physicians and patients as Sequana Medical. The
ALFApump System is the first clinical application of our core technology and
a very exciting step for the company. We look forward to making the name
'Sequana Medical' known for offering patients better options and better
outcomes in the field of fluid management," concluded Dr. Johnson.

About Sequana Medical

Sequana Medical is a Swiss medical device company dedicated to improving
patient lives through innovative technologies to manage fluid within the

    Dan Rose


will not be displayed